260 related articles for article (PubMed ID: 26596578)
1. Acute fatal metabolic complications in alkaptonuria.
Davison AS; Milan AM; Gallagher JA; Ranganath LR
J Inherit Metab Dis; 2016 Mar; 39(2):203-10. PubMed ID: 26596578
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
[TBL] [Abstract][Full Text] [Related]
3. Use of nitisinone in patients with alkaptonuria.
Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
[TBL] [Abstract][Full Text] [Related]
4. Alkaptonuria presenting with ochronotic spondyloarthropathy.
Al-Mahfoudh R; Clark S; Buxton N
Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
[TBL] [Abstract][Full Text] [Related]
5. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
Ranganath LR; Milan AM; Hughes AT; Dutton JJ; Fitzgerald R; Briggs MC; Bygott H; Psarelli EE; Cox TF; Gallagher JA; Jarvis JC; van Kan C; Hall AK; Laan D; Olsson B; Szamosi J; Rudebeck M; Kullenberg T; Cronlund A; Svensson L; Junestrand C; Ayoob H; Timmis OG; Sireau N; Le Quan Sang KH; Genovese F; Braconi D; Santucci A; Nemethova M; Zatkova A; McCaffrey J; Christensen P; Ross G; Imrich R; Rovensky J
Ann Rheum Dis; 2016 Feb; 75(2):362-7. PubMed ID: 25475116
[TBL] [Abstract][Full Text] [Related]
6. Natural history of alkaptonuria.
Phornphutkul C; Introne WJ; Perry MB; Bernardini I; Murphey MD; Fitzpatrick DL; Anderson PD; Huizing M; Anikster Y; Gerber LH; Gahl WA
N Engl J Med; 2002 Dec; 347(26):2111-21. PubMed ID: 12501223
[TBL] [Abstract][Full Text] [Related]
7. Natural history of alkaptonuria revisited: analyses based on scoring systems.
Ranganath LR; Cox TF
J Inherit Metab Dis; 2011 Dec; 34(6):1141-51. PubMed ID: 21748407
[TBL] [Abstract][Full Text] [Related]
8. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
[TBL] [Abstract][Full Text] [Related]
9. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
10. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems.
Cox TF; Ranganath L
J Inherit Metab Dis; 2011 Dec; 34(6):1153-62. PubMed ID: 21744089
[TBL] [Abstract][Full Text] [Related]
11. The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.
Milan AM; Hughes AT; Davison AS; Devine J; Usher J; Curtis S; Khedr M; Gallagher JA; Ranganath LR
Ann Clin Biochem; 2017 May; 54(3):323-330. PubMed ID: 28081634
[TBL] [Abstract][Full Text] [Related]
12. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria.
Bernini A; Spiga O; Santucci A
Curr Protein Pept Sci; 2023; 24(5):380-392. PubMed ID: 36880186
[TBL] [Abstract][Full Text] [Related]
13. Nutritional interventions for patients with alkaptonuria: A minireview.
Imrich R; Zatkova A; Lukacova O; Sedlakova J; Zanova E; Vlcek M; Penesova A; Radikova Z; Havranova A; Ranganath L
Endocr Regul; 2023 Jan; 57(1):61-67. PubMed ID: 36966367
[TBL] [Abstract][Full Text] [Related]
14. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
[TBL] [Abstract][Full Text] [Related]
15. Preventive use of nitisinone in alkaptonuria.
Wolffenbuttel BHR; Heiner-Fokkema MR; van Spronsen FJ
Orphanet J Rare Dis; 2021 Aug; 16(1):343. PubMed ID: 34344451
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients.
Ranganath LR; Heseltine T; Khedr M; Fisher MF
Mol Genet Metab; 2021 Jul; 133(3):324-331. PubMed ID: 34059444
[TBL] [Abstract][Full Text] [Related]
17. Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
Curtis SL; Norman BP; Milan AM; Gallagher JA; Olsson B; Ranganath LR; Roberts NB
Clin Biochem; 2019 Sep; 71():24-30. PubMed ID: 31228435
[TBL] [Abstract][Full Text] [Related]
18. Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.
Arnoux JB; Le Quan Sang KH; Brassier A; Grisel C; Servais A; Wippf J; Dubois S; Sireau N; Job-Deslandre C; Ranganath L; de Lonlay P
J Inherit Metab Dis; 2015 Sep; 38(5):791-6. PubMed ID: 25860819
[TBL] [Abstract][Full Text] [Related]
19. Alkaptonuria is a novel human secondary amyloidogenic disease.
Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
[TBL] [Abstract][Full Text] [Related]
20. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
